Comparative effects of a new orally active antidysrhythmic agent, Organon 6001, on the cardiac action potential of human ventricular muscle and sheep Purkinje fibres [proceedings].
D015068:17-Ketosteroids / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000731:Androstanes / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D011690:Purkinje Fibers / Q000187:drug effects*; D012756:Sheep
D015068:17-Ketosteroids; D000731:Androstanes; D000889:Anti-Arrhythmia Agents